Larimar Therapeutics Appoints John Harlow as President and COO
Larimar Therapeutics appointed John Harlow as President and Chief Operating Officer, effective September 29, 2026.
Larimar Therapeutics appointed John Harlow as President and Chief Operating Officer, effective September 29, 2026.